RecruitingPhase 1NCT02379377

18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

PET Imaging of Hepatocellular Carcinoma With 18F-FSPG


Sponsor

M.D. Anderson Cancer Center

Enrollment

110 participants

Start Date

Feb 15, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial studies fluorine F 18 L-glutamate derivative BAY94-9392 (18F-FSPG) positron emission tomography (PET) in imaging patients with liver cancer before undergoing surgery or transplant. Diagnostic procedures, such as 18F-FSPG PET, may help find and diagnose liver cancer and find out how far the disease has spread.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a new type of imaging scan called an 18F-FSPG PET scan to see if it can better detect and diagnose liver tumors before patients undergo surgery or other treatments. **You may be eligible if...** - You are 18 years of age or older - You have been diagnosed with liver cancer (hepatocellular carcinoma), a benign liver tumor, another type of liver tumor (such as bile duct cancer or cancer that has spread from the colon or pancreas), or cancer that has spread to a limited number of sites in the body - You have already had standard imaging (MRI or CT scan) as part of your care - You are being considered for surgery, liver transplant, or a radiation-based treatment for your liver tumor **You may NOT be eligible if...** - You are under 18 years old - You have liver cancer but are not a candidate for surgery, transplant, or radiation treatment - You are pregnant or breastfeeding - You have poorly controlled diabetes (fasting blood sugar over 200 mg/dL) - You have a specific aggressive type of liver cancer called the infiltrative variant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALFluorine F 18 L-glutamate Derivative 18F-FSPG

Undergo 18F-FSPG PET scan

BIOLOGICALCarbon C 11 Acetate

Undergo 11C-acetate PET scan

PROCEDUREPositron Emission Tomography

Undergo 18F-FSPG, 11C-acetate, or 18F-FDG PET

OTHERLaboratory Biomarker Analysis

Correlative studies

BIOLOGICALFluorine F 18 2-deoxy-2-(18F)fluoro-D-glucose

Undergo 18F-FDG PET scan


Locations(1)

MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02379377


Related Trials